Control of pain after photorefractive keratectomy

Journal of Refractive Surgery

Volumn 12, Issue 3, 1996, Pages 358-364

  Verma, Seema ^a   Marshall, John ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Department of Summit Technology ^*

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DICLOFENAC; LIDOCAINE; OPTHAINE; OXYBUPROCAINE; PROXYMETACAINE; TETRACAINE; UNCLASSIFIED DRUG;

ANALGESIA; ANESTHESIA COMPLICATION; ARTICLE; DRUG EFFICACY; EXCIMER LASER; HUMAN; KERATECTOMY; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RATING SCALE; TOPICAL ANESTHESIA; TOPICAL DRUG ADMINISTRATION;

ANESTHETICS, LOCAL; ANIMALS; HUMANS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PILOT PROJECTS;

EID: 0029864695     PISSN: 08830444     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tengroth B, Epstein D, Fagerholm P, Hamberg-Nystrom H, Fitzsimmons TD. Excimer laser photorefractive keratectomy for myopia: clinical results in sighted eyes. Ophthalmology. 1993;100:739-745.
2. Gartry DS, Kerr Muir MG, Marshall J. Excimer laser photorefractive keratectomy. Ophthalmology. 1992;99:1209-1219.
3. Seiler T, Wollensak J. Myopic photorefractive keratectomy with the excimer laser. One year follow-up. Ophthalmology. 1991;98:1156-1163.
4. O'Brart DPS, Corbett MC, Lohmann CP, Kerr Muir MG, Marshall J. The effects of ablation diameter on the outcome of excimer laser photorefractive keratectomy: a prospective, randomized, double blind study. In press.
5. Lohmann CP, Gartry DS, Kerr Muir MG, Timberlake GT, Fitzke FW, Marshall J. Haze in photorefractive keratectomy: its origins and consequences. Lasers and Light in Ophthalmology. 1991;4:15-34.
6. Lohmann CP, Fitzke FW, O'Brart DPS, Kerr Muir MG, Marshall J. Halos: a problem for all myopes? A comparison between spectacles, contact lenses and photorefractive keratectomy. Refract Corneal Surg. 1993;9(suppl):S72-S75.
7. O'Brart DPS, Lohmann CP, Fitzke FW, Klonos G, Corbett MC, Kerr Muir MG, Marshall J. Disturbances in night vision after excimer laser photorefractive keratectomy. Eye. 1994;8:46-51.
8. Aron-Rosa DS, Boerner CF, Bath P, Carre F, Gross M, Timsit JC,True L, Hufnagel T. Corneal wound healing after excimer laser keratectomy in a human eye. Am J Ophthalmol. 1987;103:454-464.
9. Fagerholm P, Hamberg-Nystrom H, Tengroth B. Wound healing and myopic regression following photorefractive keratectomy. Acta Ophthalmol. 1994;72:229-234.
10. Seiler T, Derse M, Pham T. Repeated excimer laser treatment after photorefractive keratectomy. Arch Ophthalmol. 1992;110:1230-1233.
11. Piebenga LW, Matta CS, Deitz MR, Tauber J, Irvine JW, Sabates FN. Excimer photorefractive keratectomy for myopia. Ophthalmology. 1993;9:1335-1345.
12. McDonald MB. Central PRK for myopia. Arch Ophthalmol. 1990;108:799-808.
13. O'Neal KP, Forgey DR, Cook YD. Excimer laser photorefractive keratectomy for myopia: six month results. Refract Corneal Surg. 1991;7:344-347.
14. Salz JJ, Macy JI, Papaioannou T, Hofbauer J, Nesburn AB. One year result of excimer laser photorefractive keratectomy for myopia. Refract Corneal Surg. 1992;8:269-273.
15. Zabel RW, Sher NA, Ostrov CS, Parker P, Lindstrom RL. Myopic excimer laser keratectomy: a preliminary report. Refract Corneal Surg. 1990;6:329-334.
16. Eiferman RA, Hoffman RS, Sher NA. Topical diclofenac reduces pain following photorefractive keratectomy (Letter). Arch Ophthalmol. 1993;111:1022.
17. Sher N, Frantz JM, Talley A, Parker P, Lane SS, Ostrov C, Carpel E, Doughman D, DeMarchi J, Lindstrom R. Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. Refract Corneal Surg. 1993;9:425-436.
18. McDonald MB, Herschel MK, Ahmed S, Varnell RL, Klyce SD, Beuerman RW. Effects of Voltaren and FML drops in post-excimer laser photorefractive keratectomy therapy. Invest Ophthalmol Vis Sci. 1993;34:803.
19. Behrendt T. Experimental study of corneal lesions produced by topical anesthesia. Am J Ophthalmol. 1956;41:99-105.
20. Epstein DL, Paton D. Keratitis from misuse of corneal anesthetics. N Engl J Med. 1968;279:396-399.
21. Henkes HE, Waubke TN. Keratitis from abuse of corneal anesthetics. Br J Ophthalmol. 1978;62:62-65.
22. Penna EP, Tabbara KF. Oxybuprocaine keratopathy: a preventable disease. Br J Ophthalmol. 1986;70:202-204.
23. Maurice DM, Singh T. The absence of corneal toxicity with low-level topical anesthesia. Am J Ophthalmol. 1985;99:691-696.
24. Bisla K, Tanelian DL. Concentration-dependent effects of lidocaine on corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1992;33:3029-3033.
25. Cherry PMH, Tutton MK, Adhikary H, Banerjee D, Garston B, Hayward JM, Ramsell T, Tolia J, Chipman ML, Bell A, Neave C, Fichte C. The treatment of pain following photorefractive keratectomy. Refract Corneal Surg. 1994;10:S222-S225.
26. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2:175-184.
27. Gunderson T, Liebman SD. Effect of local anesthetics on the regeneration of the corneal epithelium. Arch Ophthalmol. 1944;31:29-33.
28. Marr WG, Wood R, Senterfit L, Siegelman S. The effect of topical anesthetics on regeneration of corneal epithelium. Am J Ophthalmol. 1957;43:606-610.
29. Harnish JP, Hoffman F, Dumitrescu L. Side-effects of local anesthetics on the corneal epithelium of the rabbit eye. Graefes Arch Klin Exp Ophthalmol. 1975;197:71-81.
30. Boljka M, Kolar G, Vidensek J. Toxic side effects of local anesthetics on the human cornea. Br J Ophthalmol. 1994;78:386-389.
31. Pfister RR, Burstein N. The effects of ophthalmic drugs, vehicles and preservatives on corneal epithelium; a scanning electron microscope study. Invest Ophthalmol Vis Sci. 1976;15:246-259.
32. Tengroth B, Fagerholm P, Soderberg P, Hamberg-Nystrom H, Epstein D. Effect of corticosteroids in postoperative care following photorefractive keratectomies. Refract Corneal Surg. 1993;9:S61-S64.
33. Gartry DS, Kerr Muir MG, Lohmann CP, Marshall J. The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy: a prospective, randomized, double-blind trial. Arch Ophthalmol. 1992;110:944-952.
34. O'Brart DPS, Lohmann CP, Klonos G, Corbett MC, Pollock WST, Kerr Muir MG, Marshall J. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze and visual performance after photorefractive keratectomy: a prospective, randomized, observer-masked study. Ophthalmology. 1994;101:1565-1574.
35. Phillips AF, Szerenyi K, Campos M, Krueger RR, McDonnell PJ. Arachidonic acid metabolites after excimer laser corneal surgery. Arch Ophthalmol. 1993;111:1273-1278.
36. Ku EC, Lee W, Kothari HV, Scholer DW. Effect of diclofenac sodium on the arachidonic acid cascade. Am J Med. 1986;80(suppl):18-23.
37. Sher NA, Krueger RR, Teal P, Jans RG, Edmison D. The role of topical steroidal and non-steroidal anti-inflammatory drugs in the etiology of stromal infiltrates after excimer photorefractive keratectomy. Refract Corneal Surg. 1994;10:587-588.